US COVID-19 Relief Package Boosts Pharma Manufacturing Programs – More To Come?
$10bn here and $6bn there on top of what’s left from earlier CARES Act gives government more options on COVID-19 medical countermeasures.
You may also be interested in...
American Rescue Plan Act appropriated $50m to Consumer Product Safety Commission and $30.4m to Federal Trade Commission for COVID-19-related enforcement. Neither agency received funding for pandemic-related enforcement in previous relief packages.
The $500m in additional funds would support pandemic-related activities, potentially for additional staff or technology upgrades.
US FDA excludes chronic care products from list of medicines bolstered by domestic production investment and federal procurement requirements.